US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18. Ocugen’s data,
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18. Ocugen’s data,
South Korea confirmed a highly pathogenic avian influenza case in a wild bird for the first time in seven months, raising concerns over a possible transmission to poultry farms, the
The World Health Organization on Wednesday called for the urgent development of a vaccine against a bacterial infection responsible for nearly 150,000 stillbirths and infant deaths each year. A fresh
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis,
E-cigarettes could soon be prescribed on the NHS in England to help people stop smoking tobacco products, reports BBC. The Medicines and Healthcare Products Regulatory Agency is inviting manufacturers to
Needle-free vaccine patches coming soon, say researchers and makers Effective vaccines, without a needle: Since the start of the Covid pandemic, researchers have doubled down on efforts to create patches
The EU’s drug watchdog on Monday approved booster doses of Moderna’s Covid vaccine for all over-18s, amid concerns that protection levels dip after initial jabs. Spikevax is the second booster
Namibia has discontinued the use of Russia’s Sputnik V Covid-19 vaccine following concerns raised by neighbouring South Africa, the health ministry said on Saturday, reports AFP. Neighbouring South Africa earlier
A new mutated form of coronavirus that some are calling “Delta Plus” may spread more easily than regular Delta, UK experts now say. The UK Health Security Agency (UKHSA) has